Mobile App Logging for Diabetes in Pregnancy

This study is looking at whether using a mobile app called OneTouch Reveal helps pregnant women with gestational diabetes (diabetes that develops during pregnancy) or type 2 diabetes better track their blood sugar levels compared to using paper logs. The goal is to see if the app leads to more consistent logging and helps keep blood sugar levels within a healthy range. You might be able to join if you are at least 18 years old, are at least 12 weeks pregnant, and have either gestational diabetes or type 2 diabetes. The study aims to enroll 40 participants, but its current recruitment status is unclear.

Study design
This interventional study plans to enroll 40 women to compare blood sugar tracking methods.
What's involved
You would need to record your blood sugar values four times a day (fasting and after each meal) for 4 weeks.
Compensation
Not stated in the trial record.
Follow-up
The primary outcome of the study is measured at 4 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06005987

Mobile App Logging for Diabetes in Pregnancy

Recruiting
NAAges 18+InterventionalTreatment
Carolyn Zahler-Miller
~40 participants
Updated 2025-01-31 on ClinicalTrials.gov
What's tested:OneTouch Reveal application

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Compliance
Measured over 4 weeks
Gestational Diabetes Mellitus in Pregnancy
Type 2 Diabetes
1 sites across 1 states
Georgia1
  • Rebecca Keipper, MD · PRINCIPAL_INVESTIGATOR · Augusta University

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18 years and older
Verified intrauterine pregnancy
At least 12 weeks gestation
Diagnosed with either type 2 diabetes mellitus or gestational diabetes mellitus.

Exclusion

Patients with less than 4 weeks anticipated to be remaining in pregnancy
Pre-existing use of a continuous glucose monitor or other mobile application for glucose tracking
Type 1 diabetes mellitus
Non-English speaking patients
  • Compliance4 weeks

    percentage of actual blood glucose values logged compared to expected.